Pharmaceutical companies Lupin and Granules India are presently recalling nearly 9.71 lakh bottles of generic diabetes drug in the United States in wake of the possibility of the affected lot contains cancer inducing nitrosodimethylamine (NDMA) above the acceptable intake limit.
According to the latest Enforcement Report of the United States Food and Drug Administration (USFDA), drug maker Lupin is recalling 492,858 bottles of Met....
Tags : Metformin, USFDA, Lupin, Granules India, Metformin Hydrochloride,
comments (0)